Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity

Narender Nath; Musfiquidin Khan; Ramandeep Rattan; Ashutosh Mangalam; Randhir S. Makkar; Carloe de Meester; Luc Bertrand; Inderjit Singh; Yingjie Chen; Benoit Viollet; Shailendra Giri

doi:10.1016/j.bbrc.2009.05.106

Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity

Narender Nath, Musfiquidin Khan, Ramandeep Rattan, Ashutosh Mangalam, Randhir S. Makkar, Carloe de Meester, Luc Bertrand, Inderjit Singh, Yingjie Chen, Benoit Viollet, Shailendra Giri

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Abstract

AMP-activated protein kinase (AMPK) is an energy sensing metabolic switch in mammalian cells. Here, we report our novel finding that AMPK is lost in all immune cells of experimental autoimmune encephalomyelitis (EAE), an inflammatory disease of Central Nervous System (CNS). AMPKα1 is predominantly expressed in T cells and antigen presenting cells (APCs), which are primarily involved in EAE disease progression. AMPK is lost at protein level in spleen macrophages, total T cells and their subsets (CD4, CD8 and regulatory T cells) isolated from EAE afflicted animals compared to control, without affecting its mRNA levels suggesting that the loss of AMPK protein is the result of posttranscriptional modification. To examine its pathological relevance in inflammatory disease, EAE was induced in wild type (+/+) and AMPKα1 null mice (-/-) using MOG_35-55 peptide. AMPKα1^-/- mice exhibited severe EAE disease with profound infiltration of mononuclear cells compared to wild type mice however, AMPKα2 is not involved in enhancing the severity of the disease. Spleen cells isolated from AMPKα1^-/- immunized mice exhibited a significant induction in the production of IFNγ. Our study identifies AMPK as a down regulated target during disease in all immune cells and possibly restoring AMPK may serve as a novel therapeutic target in autoimmune diseases like multiple sclerosis (MS).

Original language	English (US)
Pages (from-to)	16-20
Number of pages	5
Journal	Biochemical and Biophysical Research Communications
Volume	386
Issue number	1
DOIs	https://doi.org/10.1016/j.bbrc.2009.05.106
State	Published - Aug 14 2009
Externally published	Yes

Bibliographical note

Funding Information:
The authors thank Ms. Joyce Bryan and Carrie Barnes for their technical assistance. Authors also acknowledge generous support of Prof. Inderjit Singh for providing infrastructure for conducting this study. This investigation (S.G.) was supported by Grants (RG 3810-A-1, PP1283) from the National Multiple Sclerosis Society. This work was also supported by Extramural Research Facilities Program of the National Center for Research Resources (Grants C06 RR018823 and No C06 RR015455). C.d.M. is supported by the Fund for Scientific Research in Industry and Agriculture (F.R.I.A.), Belgium. L.B. is Research Associate of the Fonds National de la Recherche Scientifique, Belgium.

Keywords

AMPK
EAE
Macrophage
Multiple sclerosis
T cells

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.bbrc.2009.05.106

OpenUrl availability

Full text

Cite this

@article{f81c4401ca2f4c2fb65146b9b6991e54,

title = "Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity",

abstract = "AMP-activated protein kinase (AMPK) is an energy sensing metabolic switch in mammalian cells. Here, we report our novel finding that AMPK is lost in all immune cells of experimental autoimmune encephalomyelitis (EAE), an inflammatory disease of Central Nervous System (CNS). AMPKα1 is predominantly expressed in T cells and antigen presenting cells (APCs), which are primarily involved in EAE disease progression. AMPK is lost at protein level in spleen macrophages, total T cells and their subsets (CD4, CD8 and regulatory T cells) isolated from EAE afflicted animals compared to control, without affecting its mRNA levels suggesting that the loss of AMPK protein is the result of posttranscriptional modification. To examine its pathological relevance in inflammatory disease, EAE was induced in wild type (+/+) and AMPKα1 null mice (-/-) using MOG35-55 peptide. AMPKα1-/- mice exhibited severe EAE disease with profound infiltration of mononuclear cells compared to wild type mice however, AMPKα2 is not involved in enhancing the severity of the disease. Spleen cells isolated from AMPKα1-/- immunized mice exhibited a significant induction in the production of IFNγ. Our study identifies AMPK as a down regulated target during disease in all immune cells and possibly restoring AMPK may serve as a novel therapeutic target in autoimmune diseases like multiple sclerosis (MS).",

keywords = "AMPK, EAE, Macrophage, Multiple sclerosis, T cells",

author = "Narender Nath and Musfiquidin Khan and Ramandeep Rattan and Ashutosh Mangalam and Makkar, {Randhir S.} and Meester, {Carloe de} and Luc Bertrand and Inderjit Singh and Yingjie Chen and Benoit Viollet and Shailendra Giri",

note = "Funding Information: The authors thank Ms. Joyce Bryan and Carrie Barnes for their technical assistance. Authors also acknowledge generous support of Prof. Inderjit Singh for providing infrastructure for conducting this study. This investigation (S.G.) was supported by Grants (RG 3810-A-1, PP1283) from the National Multiple Sclerosis Society. This work was also supported by Extramural Research Facilities Program of the National Center for Research Resources (Grants C06 RR018823 and No C06 RR015455). C.d.M. is supported by the Fund for Scientific Research in Industry and Agriculture (F.R.I.A.), Belgium. L.B. is Research Associate of the Fonds National de la Recherche Scientifique, Belgium. ",

year = "2009",

month = aug,

day = "14",

doi = "10.1016/j.bbrc.2009.05.106",

language = "English (US)",

volume = "386",

pages = "16--20",

journal = "Biochemical and Biophysical Research Communications",

issn = "0006-291X",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity

AU - Nath, Narender

AU - Khan, Musfiquidin

AU - Rattan, Ramandeep

AU - Mangalam, Ashutosh

AU - Makkar, Randhir S.

AU - Meester, Carloe de

AU - Bertrand, Luc

AU - Singh, Inderjit

AU - Chen, Yingjie

AU - Viollet, Benoit

AU - Giri, Shailendra

N1 - Funding Information: The authors thank Ms. Joyce Bryan and Carrie Barnes for their technical assistance. Authors also acknowledge generous support of Prof. Inderjit Singh for providing infrastructure for conducting this study. This investigation (S.G.) was supported by Grants (RG 3810-A-1, PP1283) from the National Multiple Sclerosis Society. This work was also supported by Extramural Research Facilities Program of the National Center for Research Resources (Grants C06 RR018823 and No C06 RR015455). C.d.M. is supported by the Fund for Scientific Research in Industry and Agriculture (F.R.I.A.), Belgium. L.B. is Research Associate of the Fonds National de la Recherche Scientifique, Belgium.

PY - 2009/8/14

Y1 - 2009/8/14

N2 - AMP-activated protein kinase (AMPK) is an energy sensing metabolic switch in mammalian cells. Here, we report our novel finding that AMPK is lost in all immune cells of experimental autoimmune encephalomyelitis (EAE), an inflammatory disease of Central Nervous System (CNS). AMPKα1 is predominantly expressed in T cells and antigen presenting cells (APCs), which are primarily involved in EAE disease progression. AMPK is lost at protein level in spleen macrophages, total T cells and their subsets (CD4, CD8 and regulatory T cells) isolated from EAE afflicted animals compared to control, without affecting its mRNA levels suggesting that the loss of AMPK protein is the result of posttranscriptional modification. To examine its pathological relevance in inflammatory disease, EAE was induced in wild type (+/+) and AMPKα1 null mice (-/-) using MOG35-55 peptide. AMPKα1-/- mice exhibited severe EAE disease with profound infiltration of mononuclear cells compared to wild type mice however, AMPKα2 is not involved in enhancing the severity of the disease. Spleen cells isolated from AMPKα1-/- immunized mice exhibited a significant induction in the production of IFNγ. Our study identifies AMPK as a down regulated target during disease in all immune cells and possibly restoring AMPK may serve as a novel therapeutic target in autoimmune diseases like multiple sclerosis (MS).

AB - AMP-activated protein kinase (AMPK) is an energy sensing metabolic switch in mammalian cells. Here, we report our novel finding that AMPK is lost in all immune cells of experimental autoimmune encephalomyelitis (EAE), an inflammatory disease of Central Nervous System (CNS). AMPKα1 is predominantly expressed in T cells and antigen presenting cells (APCs), which are primarily involved in EAE disease progression. AMPK is lost at protein level in spleen macrophages, total T cells and their subsets (CD4, CD8 and regulatory T cells) isolated from EAE afflicted animals compared to control, without affecting its mRNA levels suggesting that the loss of AMPK protein is the result of posttranscriptional modification. To examine its pathological relevance in inflammatory disease, EAE was induced in wild type (+/+) and AMPKα1 null mice (-/-) using MOG35-55 peptide. AMPKα1-/- mice exhibited severe EAE disease with profound infiltration of mononuclear cells compared to wild type mice however, AMPKα2 is not involved in enhancing the severity of the disease. Spleen cells isolated from AMPKα1-/- immunized mice exhibited a significant induction in the production of IFNγ. Our study identifies AMPK as a down regulated target during disease in all immune cells and possibly restoring AMPK may serve as a novel therapeutic target in autoimmune diseases like multiple sclerosis (MS).

KW - AMPK

KW - EAE

KW - Macrophage

KW - Multiple sclerosis

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=67649229607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649229607&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.05.106

DO - 10.1016/j.bbrc.2009.05.106

M3 - Article

C2 - 19486896

AN - SCOPUS:67649229607

SN - 0006-291X

VL - 386

SP - 16

EP - 20

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

IS - 1

ER -

Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this